Application Nr Approved Date Route Status External Links
ANDA207825 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Doxylamine Succinate And Pyridoxine Hydrochloride Delayed-Release Tablets Are Indicated For The Treatment Of Nausea And Vomiting Of Pregnancy In Women Who Do Not Respond To Conservative Management. Limitations Of Use: Doxylamine Succinate And Pyridoxine Hydrochloride Delayed-Release Tablets Have Not Been Studied In Women With Hyperemesis Gravidarum. Doxylamine Succinate And Pyridoxine Hydrochloride Delayed-Release Tablets Are A Fixed Dose Combination Drug Product Of Doxylamine Succinate, An Antihistamine, And Pyridoxine Hydrochloride, A Vitamin B6 Analog, Indicated For The Treatment Of Nausea And Vomiting Of Pregnancy In Women Who Do Not Respond To Conservative Management. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments